NASDAQ · Drug Manufacturers - Specialty & Generic

CGC (CGC) Stock

$0.92 +4.02% NASDAQ: CGC Healthcare

Valuation

MetricValue
Price$0.92
Market Cap$390.20M
P/E Ratio-0.20
P/B Ratio1.01
P/S Ratio0.81
EPS (TTM)$0.00
52-Week High$2.38
52-Week Low$0.84
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-122.79%
ROA-65.14%
ROCE-23.98%
Gross Margin-43.49%
Operating Margin-43.49%
Net Margin-84.76%
Debt/Equity0.40
Current Ratio3.14

Annual Financials (USD)

Metric20202021202220232024
Revenue$547.0M$476.0M$333.0M$297.0M$269.0M
Operating Profit$-1.2B$-1.0B$-2.6B$-229.0M$-117.0M
Net Profit$-1.7B$-310.0M$-3.3B$-657.0M$-598.0M
EPS$-4.45$-7.70$-70.70$-8.79$-5.53
Op Margin-227.5%-214.2%-789.3%-77.0%-43.5%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$6.8B$5.6B$2.4B$1.3B$918.0M
Total Liabilities$3.2B$2.0B$1.7B$800.0M$430.0M
Cash$1.2B$776.0M$668.0M$170.0M$114.0M
Borrowings$1.7B$1.6B$1.4B$668.0M$348.0M

Latest News

Why Canopy Growth Corporation (CGC) Dipped More Than Broader Market Today Zacks · Jul 13, 2026 Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know Zacks · Jul 9, 2026 Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value? Motley Fool · Jul 8, 2026 Canopy Growth Corporation (CGC) Declines More Than Market: Some Information for Investors Zacks · Jul 7, 2026 Canopy Growth: Is Another Reverse Stock Split Inevitable? Motley Fool · Jul 7, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-466.0M$-546.0M$-558.0M$-282.0M$-166.0M
Investing Cash Flow$-1.1B$183.0M$423.0M$238.0M$-59.0M
Financing Cash Flow$387.0M$3.0M$-38.0M$-36.0M$-16.0M
Net Cash Flow$-149.0M$-379.0M$-99.0M$-507.0M$-56.0M
Free Cash Flow$-640.0M$-594.0M$-568.0M$-286.0M$-177.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.52
EV / EBITDA—
FCF Yield-30.62%
Quick Ratio2.64
Interest Coverage-1.56
Return 1Y-22.64%
Return 3Y-77.09%
Return 5Y-99.51%

Ownership

Insiders Held0.25%
Institutions Held7.90%
Institutions Float Held7.92%
Institutional HolderSharesReport Date
Tidal Investments LLC8,479,8932026-03-31
Morgan Stanley1,969,6402026-03-31
Lazard Asset Management LLC1,807,9862026-03-31
Jane Street Group, LLC1,582,3122026-03-31
Goldman Sachs Group Inc1,263,6022026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACB $2.72 -0.73% 115.33 $168.48M 0.00%
ACRS $5.91 -2.96% -6.68 $825.41M 0.00%
BIOA $20.88 -4.09% -9.34 $786.12M 0.00%
CABA $2.71 -2.17% -2.23 $441.88M 0.00%
DH $0.67 -1.38% 4.29 $71.08M 0.00%

About CGC

CGC is led by CEO Luc Mongeau, employs 1,029 people, headquartered in CA, publicly traded since 2014.

CGC stock trades at $0.92 with a market capitalization of $390.20M. The stock is valued at a price-to-earnings (P/E) ratio of -0.20, price-to-book of 1.01, price-to-sales of 0.81. Over the past 52 weeks the stock has ranged between $0.84 and $2.38, and currently trades 61.3% below its 52-week high.

On profitability, CGC generates a return on equity (ROE) of -122.79%, return on capital employed of -23.98%, an operating margin of -43.49%, a net profit margin of -84.76%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides